| 000 | 01711 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511195853.0 | ||
| 264 | 0 | _c19920116 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0079-9963 | ||
| 024 | 7 |
_a10.1016/b978-0-12-571147-0.50013-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoyd, A E | |
| 245 | 0 | 0 |
_aSulfonylurea signal transduction. _h[electronic resource] |
| 260 |
_bRecent progress in hormone research _c1991 |
||
| 300 |
_a299-316; discussion 316-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aATP-Binding Cassette Transporters |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channels _xchemistry |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aPotassium Channels, Inwardly Rectifying |
| 650 | 0 | 4 |
_aReceptors, Drug _xgenetics |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xpharmacology |
| 650 | 0 | 4 | _aSulfonylurea Receptors |
| 700 | 1 | _aAguilar-Bryan, L | |
| 700 | 1 | _aBryan, J | |
| 700 | 1 | _aKunze, D L | |
| 700 | 1 | _aMoss, L | |
| 700 | 1 | _aNelson, D A | |
| 700 | 1 | _aRajan, A S | |
| 700 | 1 | _aRaef, H | |
| 700 | 1 | _aXiang, H D | |
| 700 | 1 | _aYaney, G C | |
| 773 | 0 |
_tRecent progress in hormone research _gvol. 47 _gp. 299-316; discussion 316-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/b978-0-12-571147-0.50013-5 _zAvailable from publisher's website |
| 999 |
_c1667085 _d1667085 |
||